Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Biora Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biora Therapeutics Inc market cap is $5.00.
What is the 52-week high for Biora Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biora Therapeutics Inc 52 week high is $0.34 as of March 02, 2026.